Search Results - "Eddlemon, Paul"
-
1
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Published in The New England journal of medicine (18-11-1999)“…Multiple myeloma accounts for approximately 1 percent of all cancers and 10 percent of hematologic cancers. It is incurable with conventional chemotherapy. 1…”
Get full text
Journal Article -
2
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
Published in Blood (15-07-2001)“…This report of a phase 2 trial of thalidomide (THAL) (200 mg/d; 200 mg increment every 2 weeks to 800 mg) for 169 patients with advanced myeloma (MM) (abnormal…”
Get full text
Journal Article -
3
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation
Published in British journal of haematology (01-09-2004)“…Summary A group of 256 newly diagnosed myeloma patients were enrolled in a phase III study that included 4 monthly cycles of induction chemotherapy and tandem…”
Get full text
Journal Article -
4
CGO: utilizing and integrating gene expression microarray data in clinical research and data management
Published in Bioinformatics (01-02-2002)“…Clinical GeneOrganizer (CGO) is a novel windows-based archiving, organization and data mining software for the integration of gene expression profiling in…”
Get full text
Journal Article